Cardiovascular Diseases Center, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China.
Evid Based Complement Alternat Med. 2012;2012:184503. doi: 10.1155/2012/184503. Epub 2012 Feb 21.
Atherothrombosis, which directly threatens people's health and lives, is the main cause of morbidity and mortality all over the world. Platelets play a key role in the development of acute coronary syndromes (ACSs) and contribute to cardiovascular events. Oral antiplatelet drugs are a milestone in the therapy of cardiovascular atherothrombotic diseases. In recent years, many reports have shown the possibility that "resistance" to oral anti-platelet drugs and many adverse reactions, such as serious bleeding risk, which provides an impetus for developing new anti-platelet drugs possesses highly efficiency and fewer adverse effects. Study on the blood stasis syndrome and promoting blood circulation and removing blood stasis is the most active field of research of integration of traditional and western medicine in China. Blood-stasis syndrome and platelet activation have close relationship, many Chinese herb and formulas for promoting blood circulation and removing blood stasis possess definite anti-platelet effect. This paper covers the progress of anti-platelet mechanism of Chinese herb and formulas for promoting blood circulation and removing blood stasis and is to be deeply discussed in further research.
动脉粥样硬化血栓形成直接威胁着人们的健康和生命,是全世界发病率和死亡率的主要原因。血小板在急性冠状动脉综合征(ACS)的发展中起着关键作用,并导致心血管事件的发生。口服抗血小板药物是心血管动脉粥样硬化血栓形成疾病治疗的一个里程碑。近年来,许多报道表明,口服抗血小板药物“抵抗”和许多不良反应(如严重出血风险)的可能性,为开发具有高效性和更少不良反应的新型抗血小板药物提供了动力。血瘀证与活血化瘀的研究是中西医结合最活跃的研究领域。血瘀证与血小板活化密切相关,许多活血化瘀中药和方剂具有明确的抗血小板作用。本文综述了活血化瘀中药和方剂的抗血小板作用机制的研究进展,并将在进一步的研究中进行深入探讨。